Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
There is currently no known genetic disease linked to prolactin (Prl) or its receptor (PrlR) in humans. Given the essential role of this hormonal system in breast physiology, we reasoned that genetic anomalies of Prl/PrlR genes may be related to the occurrence of breast diseases with high proliferative potential. Multiple fibroadenomas (MFA) are benign breast tumors which appear most frequently in young women, including at puberty, when Prl has well-recognized proliferative actions on the breast. In a prospective study involving 74 MFA patients and 170 control subjects, we identified four patients harboring a heterozygous single nucleotide polymorphism in exon 6 of the PrlR gene, encoding Ile(146)-->Leu substitution in its extracellular domain. This sole substitution was sufficient to confer constitutive activity to the receptor variant (PrlR(I146L)), as assessed in three reconstituted cell models (Ba/F3, HEK293 and MCF-7 cells) by Prl-independent (i) PrlR tyrosine phosphorylation, (ii) activation of signal transducer and activator of transcription 5 (STAT5) signaling, (iii) transcriptional activity toward a Prl-responsive reporter gene, and (iv) cell proliferation and protection from cell death. Constitutive activity of PrlR(I146L) in the breast sample from a patient was supported by increased STAT5 signaling. This is a unique description of a functional mutation of the PrlR associated with a human disease. Hallmarks of constitutive activity were all reversed by a specific PrlR antagonist, which opens potential therapeutic approaches for MFA, or any other disease that could be associated with this mutation in future.
Bogorad
Roman L
RL
Institut National de la Santé et de la Recherche Médicale U845, Equipe Prl, GH et tumeurs, Centre de Recherche Croissance et Signalisation, F-75015 Paris, France.
Courtillot
Carine
C
Mestayer
Chidi
C
Bernichtein
Sophie
S
Harutyunyan
Lilya
L
Jomain
Jean-Baptiste
JB
Bachelot
Anne
A
Kuttenn
Frédérique
F
Kelly
Paul A
PA
Goffin
Vincent
V
Touraine
Philippe
P
D000328:Adult; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism*; D016022:Case-Control Studies; D002460:Cell Line; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005091:Exons / Q000235:genetics; D005260:Female; D018226:Fibroadenoma / Q000235:genetics* / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects; D005838:Genotype; D006801:Humans; D007150:Immunohistochemistry; D020125:Mutation, Missense; D011446:Prospective Studies; D011981:Receptors, Prolactin / Q000819:agonists / Q000235:genetics* / Q000378:metabolism*; D050799:STAT5 Transcription Factor / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D020032:Tyrphostins / Q000494:pharmacology
D004791:Enzyme Inhibitors; D011981:Receptors, Prolactin; D050799:STAT5 Transcription Factor; D020032:Tyrphostins; C095512:alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
N Engl J Med. 2005 Jul 21;353(3):275-85
16034013
Mol Endocrinol. 1996 Jan;10(1):45-56
8838144
Recent Prog Horm Res. 2003;58:297-323
12795425
Acta Obstet Gynecol Scand. 1987;66(6):483-8
3321867
Endocrinology. 2007 Mar;148(3):989-1008
17138649
Int J Cancer. 2004 Feb 20;108(5):665-71
14696092
Endocr Rev. 1998 Jun;19(3):225-68
9626554
Br J Cancer. 2007 Mar 12;96(5):841-4
17299388
J Natl Cancer Inst. 1999 Apr 7;91(7):629-34
10203283
J Clin Endocrinol Metab. 1998 Feb;83(2):667-74
9467590
Curr Med Res Opin. 2004 Apr;20(4):533-40
15119991
Nat Struct Biol. 2000 Sep;7(9):808-15
10966654
J Mammary Gland Biol Neoplasia. 2005 Oct;10(4):325-35
16900392
J Clin Endocrinol Metab. 2001 Aug;86(8):3826-32
11502819
J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):41-53
18246319
Front Biosci. 2000 Mar 01;5:D343-52
10704433
BMC Med Genet. 2007 Dec 01;8:72
18053149
J Biol Chem. 1999 Apr 9;274(15):10024-34
10187780
J Endocrinol. 2001 Oct;171(1):R1-4
11572805
Nat Clin Pract Endocrinol Metab. 2006 Oct;2(10):571-81
17024156
J Biol Chem. 1996 Nov 22;271(47):29707-14
8939904
J Biol Chem. 2003 Sep 19;278(38):35988-99
12824168
J Clin Endocrinol Metab. 2006 Feb;91(2):555-62
16278261
J Mammary Gland Biol Neoplasia. 2002 Jan;7(1):49-66
12160086
J Clin Endocrinol Metab. 2006 Apr;91(4):1513-9
16434456
J Clin Oncol. 2004 Jun 1;22(11):2053-60
15169792
J Clin Pathol. 2001 Dec;54(12):956-60
11729217
Oncogene. 2003 Jul 24;22(30):4664-74
12879011
Endocrinology. 2006 Sep;147(9):4056-66
16809439
Biol Reprod. 2004 Mar;70(3):718-28
14613905
J Endocrinol. 2006 Aug;190(2):271-85
16899561
Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):4031-5
7537382
Endocrine. 2003 Feb-Mar;20(1-2):177-90
12668884